Back to Products
Tablet
LINZOVIBE-600
Linezolid (600 mg)
Ramitra Biotech presents LINZOVIBE-600, containing Linezolid (600 mg), a high-trust Tablet in 10 x 10 Aluminium packing validated for quality assurance and certified under WHO-GMP protocols for healthcare providers across India.
📋 Specifications
| Product Name | LINZOVIBE-600 |
|---|---|
| Composition | Linezolid (600 mg) |
| Category | Tablet |
| Packaging | 10 x 10 Aluminium |
| Certifications | WHO-GMP Certified / ISO 9001:2015 Approved |
| Franchise Availability | Available for PCD Franchise |
Product Indications & Details
LINZOVIBE-600 contains Linezolid 600 mg in tablet form, offering advanced antibacterial therapy for tough bacterial infections.
Formulated to treat serious Gram-positive infections including Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus.
Inhibits bacterial protein synthesis at an early stage to effectively stop infection progression and support recovery.
Indicated for complicated skin and soft tissue infections as well as hospital-acquired and community-acquired pneumonia.
Comes in high-grade 10 x 10 aluminum packaging to ensure drug stability, safety, and extended shelf life.
Manufactured by Ramitra Biotech adhering to strict quality controls to ensure maximum efficacy and clinical reliability.
Quantity
